SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " clinic " 2,321 found 🔀 AI-powered Shuffle
Low-fat vegan diet helps people lose weight without eating less
A low-fat vegan diet may help people lose weight without counting calories, shrinking portions, or feeling constantly hungry. In a 16-week clinical trial, people eating mostly fruits, vegetables, grains, and legumes consumed about 357 fewer calories per day even though the total amount of food they ate barely changed.
Wildfire smoke may be hurting Iowans' physical and mental health
Even with all the recent rain, much of Iowa’s northern half remains under a moderate health advisory due to smoke from distant wildfires, and a mental health expert says that smoke is affecting more than just people’s lungs. Clinical health psychologist Dr. Kristi White says many of her patients are bringing up the smoky conditions […]
Healthcare AI likened to a sleeping giant waiting to wake up in many hospitals not named Mayo Clinic
What would it take to put just about every U.S. hospital on par with Mayo Clinic in sheer quality of care? Not a lot more than better use of AI.
ANTHC partners with UAA to offer local clinical rotations for healthcare students
Dr. Jay Butler, dean of the UAA College of Health, said the partnership will keep local students from leaving the state for clinical rotations.
How menopause can impact mental health
Dr. Lulu Zhao, a mood disorder specialist at Cleveland Clinic, says during perimenopause, a woman’s hormone patterns can become erratic, which can impact their mental health.
Charleston Southern University to open new residence hall, health clinic Monday
Charleston Southern University will hold ribbon cutting ceremonies Monday for two new campus buildings.
You Don’t Need 10,000 Steps to Help Your Heart
"Why don’t we, as clinicians, approach physical inactivity the way we do other major cardiovascular risk factors?" writes cardiologist Sadiya Khan in an essay for TIME.
Guest Commentary: For rural Floridians, better healthcare starts with better transportation
For many rural residents, access to healthcare doesn’t end with whether a provider or clinic exists. It begins with whether they can get there.
New cardiovascular health clinic opens in South Arkansas
Area residents now have another option for specialty care regarding heart health in South Arkansas.
Ethicists: Clinicians aren’t wrong to expect more from certain patients’ families—but they wouldn’t be right to request it, either
Many nurses have spent untold hours at the bedsides of frail and fading inpatients who, despite having blood relatives in the vicinity, rarely receive visitors. In these scenarios, it’s only human for a healthcare worker to feel some measure of resentment toward the absentee family.
You want to join a clinical trial. What to know about the hurdles
HHS began an effort to streamline clinical research, and legislation is pending in Congress. But patients and providers face participation challenges.
In a Heartbeat: Navigating the intersection of AI and personal healthcare
The use of artificial intelligence is becoming ubiquitous, but when it comes to health care, determining when and where organic intelligence should drive action could be a lifesaving distinction. Dr. Jose Francisco Abad, a family medicine physician and certified clinical informatics specialist guiding AI implementation at UPMC, recently parsed the
Medicare approves new technology add-on payment for inpatient radiology AI solution
The federal insurance program for seniors will pay a maximum of $137.53 per case for Aidoc's CARE (Clinical AI Reasoning Engine) Multi-Triage CT Body tool.
Cardiac CT links air pollution to increased risk of coronary disease
Cardiac CT scans may give clinicians a way to visualize the effects of environmental exposure before cardiovascular events even occur.
Nevada Health Centers adds Saturday clinic hours at two Las Vegas-area locations
Nevada Health Centers is expanding weekend access to care by offering Saturday hours at two locations in the Las Vegas area on Saturday, Aug. 15.The organizatio
Culinary Health Fund opens fourth Las Vegas Valley clinic with new Tropicana center
The Culinary Health Fund marked a major expansion of its health care network Thursday with the grand opening of Culinary Health Center – Tropicana, a new two-st
MVNU launches online Master of Science in Speech-Language Pathology
MOUNT VERNON — Mount Vernon Nazarene University has launched its Master of Science in Speech-Language Pathology (MS-SLP), a graduate program featuring fully online coursework and extensive clinical training to prepare the next generation of skilled speech-language pathologists. Offered through MVNU’s College of Adult and Professional Studies, the program prepares students to diagnose and treat a […]
Epic launches new diagnostic image exchange
Clinicians can now retrieve diagnostic-quality images from other health systems and patients can "ditch the disc," the company says. Next up: The healthcare IT giant wants TEFCA to adopt it as a standard.
On-Demand Virtual Clinic from MCN Health
MUSCOGEE NATION — MCN Health’s On-Demand Clinic is now available to all employees and their family members, ages 12 and older. The clinic provides convenient
SGMC Health Welcomes Internists Brandon Rockwell, MD, and Justin Owens, DO
SGMC Health welcomes Internal Medicine physicians Brandon Rockwell, MD, and Justin Owens, DO, to the health system. Drs. Rockwell and Owens will see patients at SGMC Valdosta Medical Clinic in Valdosta beginning August 24.
U.S., U.K. health care systems share a fatal flaw
“The default to biomedical responses means that clinics and hospitals are increasingly absorbing the costs of social problems,” writes Kyle Vanelli.
UNT Health Fort Worth expects nearly flat revenue, higher spending in 2027
The university expects a small revenue increase and raises expenditures $8.2 million as it pursues enrollment, research and clinical growth.
Spanberger touts progress keeping insulin, prescriptions affordable during tour of Northern Va. health clinic
Virginia Gov. Abigail Spanberger is touting the progress the state has made in capping insulin costs and keeping prescription drugs affordable.
New health clinic for Culinary members opening west of Las Vegas Strip
Culinary leaders, joined by politicians and others, held a ribbon-cutting ceremony Thursday for the newly built Culinary Health Center at the southwest corner of Tropicana Avenue and Cameron Street...
Nurses at 10 SSM Health outpatient clinics in Dane County working to unionize
Nurses at 10 outpatient clinics in Dane County are working to unionize, saying they were inspired by a similar effort at SSM Health St. Mary’s Hospital in Madison.
Vaccine Clinic at the Council on Aging (COA)
The Central MA Regional Health Dept. is partnering with Shaw's for a vaccine clinic on 9/9/26 from 9am-11:30am at the C.O.A., 98 Maple Avenue. Walk-in appointments available for Flu & COVID shots
AI needs science’s search history
“Actually, that’s where the gold is,” said Alasdair Russell, my graduate school friend who leads a pre-clinical genome editing group at Cambridge. He was talking about the winding road of science that is omitted from published papers. “When you’re discussing how to do the experiment, and why this way is better than another way, and what does the data really mean? I know what it shows, but what does it mean?” At RAAIS 2026, he described how his group has begun logging the twisting path of discovery as it happens, recording the verbal and written exchanges that normally disappear. Ideas become nodes in a living graph: they branch when a meeting produces two plausible experiments, merge when separate lines of evidence converge, and go dark when someone quietly stops pursuing them. In his implementation, one agent scores novelty, while another tries to learn “how scientists think and how they navigate through a complex world of data,” so that high-potential nodes can trigger deeper investigation. As frontier AI labs deploy agents toward scientific discovery, giving AI authentic scientific taste remains a trillion-dollar dilemma. The bottleneck is that the record we have kept for centuries of science might be insufficient to get us there. The experiments that never make the paper Peter Medawar, 1960 Nobel laureate and “father of transplantation,” asked in 1963 whether the scientific paper was a fraud, and answered yes: the form of the paper misrepresents the thinking that produced it. Sixty years on, the diagnosis is unchanged. A paper presents a clean progression from hypothesis to result to conclusion. Lost along the way are the unconventional theories, the abandoned or unaffordable methods, and the underwhelming and inconclusive data. It reads like a browser history with every dead end deleted: the ten open tabs, the four rephrased queries, the wrong turn down a subforum. All scrubbed, leaving one clean path from question to answer as the canonical path. What has changed since then is that the discarded material is now worth something. No high-impact journal wants these artifacts, but raw trial and error is the most likely source of the training data required to develop scientific intuition, or what researchers call taste. Earlier attempts to capture the discards were motivated by scientific integrity. The Journal of Negative Results in Biomedicine launched in 2002 to publish rigorous studies that disputed established models or exposed ineffective treatments. Its archive preserved negative conclusions after they had become papers, rather than the live alternatives and arguments that produced them. BioMed Central closed it in 2017, saying the mission had been served now that other journals publish null results. A less generous reading is that in fifteen years it published around 200 papers because almost nobody wants to read a negative result, let alone write one up when it will not count toward academic tenure. AI models are different. Even an uninteresting negative result can be useful, provided it is labeled. Earlier this year, Anthropic put a version of this to the test. The company pulled 129 decision points from real Claude Code sessions between January and March 2026, showed models the work up to a human detour, and asked what should happen next. Claude Mythos Preview beat the human choice 64% of the time, while Opus 4.5 managed 51%. The comparison was tilted toward the models because Anthropic deliberately chose moments where the human decision had room for improvement. On 127 further scenarios where the human action was already strong, the models improved on it only about 20% of the time. The study was possible because Anthropic’s researchers work inside a tool that logs by default. The reasoning, detours and outcome are produced in the same working environment. Biology has no equivalent. Its reasoning happens in hallways, at benches, in Slack threads and on whiteboards, while the outcome arrives weeks later somewhere else. The record has to emerge from the work itself. Ask scientists to reconstruct it afterwards and we’ll create another polished account. Subscribe A log is not a label Before any of this becomes training data, a negative result has to say what failed. The first paper published in the Journal of Negative Results in Biomedicine examined 234 negative studies across five leading medical journals. Only 30% discussed statistical power, and half clearly defined a primary outcome. Tell a model an experiment failed, without telling it whether the assay was underpowered, a reagent had degraded, or the hypothesis was simply wrong, and it will learn noise with confidence. Decision histories have a second missing label too. When a lab considers five experiments and runs one, only the chosen branch returns an outcome. The other four are experimental counterfactuals. Researchers call this the selective labels problem: the data reveal results only for the actions someone chose to take. Such a record can teach a model to imitate a lab’s taste, but it cannot establish that the taste was good. It also smuggles local constraints into general lessons. A lab that never ran cryo-EM because it did not own a microscope teaches a model that cryo-EM is rarely the right call. Alasdair’s nodes preserve the candidate set, which is the necessary first step. To be useful, each decision record needs six fields: The evidence available at that moment, and nothing that arrived later. The candidates considered, including the ones dismissed in a sentence. For each candidate: the expected result, the confidence attached to it, and the cost in time and money. The route chosen, and the reason. What happened next. How the evidence changed the scientist’s view. These must be timestamped before the outcome, because hindsight turns uncertainty into inevitability. Disagreement also has to survive. Averaging three scientists into one clean rationale reproduces exactly the information loss we are trying to fix. But there is an obvious failure mode here. Once decisions are logged and scored, people log for the record post-facto. Anyone who has watched an electronic lab notebook fill up with retrospective tidying knows how quickly a research tool becomes a compliance exercise. A record that costs a scientist ten minutes of honest reflection per decision is worth far more than one that costs an hour of performance. A publication initiative called Registered Reports offers a useful starting point. Here, researchers submit their rationale, methods and analysis plan for peer review before the data exist, and the journal commits in principle to publish if they follow the approved plan. Nature has now expanded the format across every field it covers. This approach to paper writing timestamps intent before the outcome, but it freezes one plan. A useful search history must also preserve how the plan changed, which alternatives were rejected, when, and on what evidence. Subscribe Run the runner-up Autonomous labs show what happens when decisions and outcomes are connected in a loop. Liverpool’s mobile robotic chemist ran 688 experiments over eight days in a ten-variable formulation space. A batched Bayesian search used each result to choose the next experiments and found photocatalyst mixtures six times more active than the starting formulations. Every completed experiment changed what the system did next. The robot optimized within a goal and search space that humans had already chosen. It did not decide which scientific question mattered. So what this work demonstrates is narrower, but still useful: a search history pays off when the options return standardized outcomes quickly. Open-ended biology is harder because branches can take weeks and the discarded alternatives may never be run. Some exploration therefore has to be bought. Where two branches are plausible and the stakes justify the cost, a lab should sometimes run the runner-up. Otherwise the record captures what today’s scientists usually chose and stays silent on what they systematically overlooked. A funder could ring-fence a small fraction of a grant for the branch not taken, provided that the decision record and the outcome are both deposited. That costs money, but so does having every lab rediscover the same abandoned path. Test whether taste transfers When it comes time to evaluate if our new AI system exhibits taste, the comparison should run across laboratories and fields. At selected decision points in a live research campaign, we should freeze the six fields: the evidence, the candidates, expected results, confidence, costs and the choice made. Experts then rank the options before the outcomes are known, and those outcomes are checked independently later. We could give models one of two diets - papers alone, or papers plus decision histories - and ask them to rank the next experiment on unfamiliar projects. Then, we score information gained per dollar and week, calibration, and how quickly weak branches are abandoned. If histories improve choices only inside the lab that produced them, they amount to useful organizational memory. If they improve choices on unfamiliar problems elsewhere, Alasdair’s group will have captured something science has never managed to write down: a transferable record of taste. Until that happens, a scientific search history is a promising record, not yet a training set.
The intelligent hospital room works for everyone
Picture an inpatient room where the bedside nurse, virtual clinician, patient and operational leader are connected through a unified care environment,
Azitra, Inc. Announces Q2 2026 Results and Provides Business Updates
/PRNewswire/ -- Azitra, Inc. ("Azitra" or the "Company") (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative...
Intermountain Health Names Veteran Leader as New Peaks Region President
Intermountain Health has selected Scott Peek as the new region president to oversee business and clinical operations across the enterprise’s markets in Colorado, Montana, Eastern Wyoming, and New Mexico, known as the Peaks Region. Most recently Peek has served as the operational lead for the region and as the market president for the Colorado ...
The Norfolk Department of Public Health to host Back to School Clinic event
NORFOLK, Va. (WAVY) — The Norfolk Department of Public Health will host a Back to School Clinic event next Thursday so families can be prepared for the upcoming school year, according to a pr…
FSU Health Lifestyle Medicine Clinic opens registration for LEADR diabetes remission program
The FSU Health Lifestyle Medicine Clinic is now accepting registrations for a 12-week program beginning Aug. 26 designed to help individuals with
MVP leads to health discoveries for Veterans like you
Research findings from VA’s MVP are helping move discoveries toward use in clinical care, improving health and wellness for all Veterans.
Small Business Spotlight: Specialty dental practice takes root on Market St.
WHAT MADE YOU WANT TO OPEN BLUE HERON ROOT CANAL SPECIALISTS? OWNER SARAH ERMOSHKIN: “I’ve always been an entrepreneur at heart. When I was 23 years old, I owned a cafe in Seattle, where I even fought to oppose oppressive sales taxes on espresso drinks. After selling that business, I got married and started a family. Once my children were in school, I attended dental school through the Navy Health Professions Scholarship Program (HPSP), which covered my tuition and provided a stipend. From the beginning, my goal was to eventually own my own practice after completing my military service. The work I do is incredibly rewarding and being able to create an environment that puts patients first while helping employees grow professionally makes every day as a business owner meaningful.” WHAT DOES YOUR BUSINESS PROVIDE? ERMOSHKIN: “Endodontists are often called ‘pain doctors’ because our primary mission is to relieve pain and save natural teeth. We specialize in root canal therapy, retreatment of nonhealing root canals, treatment of root resorption, apicoectomies – microsurgical root-end procedures – and vital pulp therapy for children. Our goal is to preserve teeth that might otherwise need to be extracted and replaced with implants. Saving a patient’s natural tooth is almost always the best long-term solution for their oral health.” HOW DOES YOUR MILITARY TRAINING HELP YOUR BUSINESS? ERMOSHKIN: “My military service taught me how to lead, collaborate and make decisions under pressure. I worked closely with senior leadership while treating a large patient population and collaborating with specialists across multiple disciplines. During the COVID-19 pandemic, (I) served a dual role as Navy dentist and as the public affairs officer for Naval Health Clinic Annapolis, where I helped develop medical and dental communications for the midshipmen and support staff, while coordinating with the broader Navy Capital Region. We worked closely with other military treatment facilities to share best practices and deliver consistent public health messaging. Those leadership experiences continue to shape how I lead my team and serve our patients today.” WHAT CHALLENGES ARE YOU FACING RIGHT NOW IN YOUR BUSINESS? ERMOSHKIN: “One of our biggest challenges is overcoming the misinformation surrounding root canal treatment. Root canals are safe, effective and often the best way to relieve pain while preserving a natural tooth. Unfortunately, many people choose extraction because they believe it’s less expensive or because they’ve seen misleading information online. What they may not realize is that losing a tooth can lead to shifting teeth, changes in the way they bite and chew and significantly higher costs to restore their smile later.”
The secret AI-startup project I’ve been working on the last six months
In this edition of STAT's AI Prognosis: The messy reality of hastily developing and selling AI tools to clinics, and other health AI news.
Northwestern earns CACREP accreditation for clinical mental health counseling
Northwestern College’s master’s program in clinical mental health counseling has received accreditation from the Council for Accreditation of Counseling and Related Educational Programs (CACREP), the premier nationally recognized accrediting organization for counseling education programs.
Coalition for Health AI (CHAI) Convenes New Health AI Cybersecurity Work Group
/PRNewswire/ -- Today, Coalition for Health AI (CHAI), a nonprofit organization founded by clinicians to advance responsible health AI, announced new efforts...
Factors that make radiologists less likely to be fooled by large language models
Successful radiologist-LLM collaboration depends on confidence in the AI model, along with the reader possessing key clinical expertise, according to new research.
Is Lemon Juice Good for You? 6 Health Benefits To Know
Lemon juice is packed with vitamin C and other vital nutrients. A registered dietitian shares its health benefits and how to add it to your menu.
Samsung is Starting to Catch Up to Apple on Hearing Health
Samsung today said its Galaxy Buds Hearing Aid feature has been cleared by the U.S. FDA, which means hearing aid capabilities will be coming to the Galaxy Buds in the fourth quarter of 2026. Samsung will join Apple in offering over-the-counter hearing aid functionality. Apple added an FDA-cleared hearing health feature to the AirPods back in 2024, allowing them to be used as a clinical-grade hearing aid.
As Candida auris spreads, UT Health San Antonio scientist highlights growing threat of antifungal resistance
Life-threatening fungus now in 27 states; Texas with second-most clinical cases Contact: Steven Lee, (210) 450-3823, lees22@uthscsa.edu Content provided by Claire Kowalick SAN ANTONIO, Aug. 11, 2026 – As cases of the potentially deadly drug-resistant fungal infection Candida auris have spread to 27 states, including Texas with the second-highest number, a scientist at UT Health […]
AHA resource: Economic Impact of Disparities in Health Outcomes
The AHA Aug. 11 released a new resource guide designed to address a critical gap by helping leaders understand and quantify the economic burden of disparities of health outcomes. The guide provides practical methods to identify and assess the financial impact of health disparities, along with data-driven approaches to implement interventions that both improve outcomes and reduce costs. READ MORE
Campbell unites pharmaceutical science, clinical research in future-focused degree
The reimagined bachelor’s program prepares students for careers across the entire drug development lifecycle, with an emphasis on hands-on experience… More on this post
Intensity Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
/PRNewswire/ -- Intensity Therapeutics, Inc. ("Intensity" or "the Company") (Nasdaq: INTS), a late-stage clinical biotechnology company focused on the...
Formulogic Debuts in Singapore with Science-Driven Barrier Care for Southeast Asia's Sensitive Skin
Formulogic, a science- and evidence-driven dermocosmetic brand dedicated to sensitive skin, developed through dermatological research and clinical validation, officially debuted in Singapore at CONNEX-C Asia 2026, jointly organized by Society of Cosmetic Scientists (Singapore) (SCSS) and Lee Kong Chian School of Medicine, unveiling its evidence-based barrier care philosophy and a comprehensive skincare system designed specifically for Southeast Asia's unique climate and skin concerns.
Nurses seek a seat at the table as they fight expanding clinical AI
Nurses, who make up the largest part of the health care workforce, say clinical artificial intelligence poses a threat to their jobs, and patients.
UToledo Health Rehab Helps 84-Year-Old Qualify for National Senior Games
Ab Khan rebuilt his strength at UToledo Health's Cardiopulmonary Rehabilitation Clinic and earned a gold medal in power walking at the Ohio Senior Olympics qualifying event.
Should You Try Ube?
Ube is a vibrant purple yam that packs vitamin C, fiber and antioxidants into every bite. A registered dietitian explains how it can benefit your health.
Biohaven Reports Recent Business Developments and Second Quarter 2026 Financial Results
First extracellular protein degraders in the clinic demonstrate rapid and robust pharmacodynamic effects and compelling safety in nearly 200 individuals dosed,...
New AI for Health Initiative Connects Computer Science and Medicine
Led by the UC Davis Department of Computer Science, the AI for Health Initiative will connect researchers and clinicians across disciplines to advance responsible AI use in medicine, support student training and strengthen partnerships with UC Davis Health.
New AI for Health Initiative Connects Computer Science and Medicine
Led by the UC Davis Department of Computer Science, the AI for Health Initiative will connect researchers and clinicians across disciplines to advance responsible AI use in medicine, support student training and strengthen partnerships with UC Davis Health.
Pioneer cardiologist Robert Frye remembered for kindness, ‘unwavering focus’ on his patients
Robert L. Frye, MD, spent more than 60 years with Mayo Clinic. He was also a former president of the American College of Cardiology.
Thousands of Endangered Species Condoms Distributed to Health Clinics, Mutual Aid Groups After Federal Funding Cuts
TUCSON, Ariz.— The Center for Biological Diversity has distributed more than 20,000 free Endangered Species Condoms so far this year to health clinics, mutual aid groups and social service organizations in the wake of federal funding cuts, including recent cuts to the Teen Pregnancy Prevention Program.
AbCellera women’s health data top ‘most aggressive upside scenario,’ putting Astellas and Bayer on notice
AbCellera has reported phase 2 results “beyond even the most aggressive upside scenario” that its CEO dared to consider, boosting the biotech’s chances of challenging Astellas and Bayer for a women’s health market. The phase 2 clinical trial compared ABCL635, an antibody targeting NK3R, to placebo in patients with hot flashes caused by menopause. Investigators enrolled 92 postmenopausal women experiencing a mean of about 10 moderate or severe hot flashes per day. By Week 4, the number of moderate or severe hot flashes had fallen by a mean of 8.8 on ABCL635 and by 3.5 on placebo. That statistically significant, placebo-adjusted reduction of 5.3 hit the trial’s primary endpoint. The level of efficacy also cleared the bar set by existing drugs. While cross-trial comparisons can be misleading, AbCellera CEO Carl Hansen, Ph.D., had seen enough to start hyping the program. “We now view ABCL635 as a potential best-in-class non-hormonal therapy with strong differentiation against approved NK3R competitors across all important dimensions, including efficacy, safety, dosing and convenience,” Hansen said on a Monday morning conference call with investors to discuss the data. “We believe ABCL635 is now a highly de-risked program.” Last week, Hansen used AbCellera’s earnings call to set expectations for readout, with the CEO defining success as a clean safety profile and efficacy comparable to the two approved small molecules. The data vaulted over that bar. Astellas linked (PDF) one of the small molecules, Veozah, to placebo-adjusted reductions in hot flash frequency of 2.1 and 2.6 at Week 4 of its two phase 3 trials. Bayer reported (PDF) placebo-adjusted reductions of 3.04 and 3.29 at Week 4 of pivotal studies for its small molecule, Lynkuet. At 5.3, the placebo-adjusted reduction in AbCellera’s trial comfortably cleared the standard set by the incumbents. Veozah and Lynkuet came to market based on evidence of their ability to reduce the frequency and severity of hot flashes. AbCellera’s phase 2 study covered both endpoints, with the Canadian biotech reporting a mean reduction in severity of 1.4 points at Week 4 on ABCL635, compared to 0.3 points for placebo. Again, the placebo-adjusted result compares favorably to data on Veozah and Lynkuet. Analysts shared Hansen’s enthusiasm for the data. The phase 2 results “firmly validate ABCL635 as a potentially best-in-class treatment,” BMO Capital Markets analysts said in a note to investors Monday. ABCL635’s apparent efficacy edge “is likely attributable to the higher dosing/target engagement the asset is able to reach vs. the oral agents due to its wider therapeutic index,” the analysts added. The analysts, who model $2.3 billion in unadjusted peak sales for ABCL635, flagged the safety profile as another positive of the phase 2 readout. While Veozah carries a boxed warning for liver damage, nobody on ABCL635 in the phase 2 trial had elevated liver enzymes or bilirubin values. If replicated in phase 3, the lack of a liver signal could allow approval without the monitoring requirements imposed on Veozah. Investors appeared equally enthused, sending AbCellera's stock up 32% to $9.21 in premarket trading Monday from a Friday closing price of $6.93. Next, AbCellera will collect the Week 12 data and talk to its advisors about further development. The results open up “a wide variety of possibilities of how we might take this forward into phase 3 studies to truly maximize the value of the asset and make sure that ABCL635 is able to demonstrate its differentiation potential,” Sarah Noonberg, M.D., Ph.D., AbCellera’s chief medical officer, told investors.
With Medicaid cuts ahead, Louisiana’s rural health providers battle over payments
As the pool of Medicaid patients shrinks and Medicaid funding runs up against new limits, independently owned health clinics will receive a much larger share of what’s available once their new reimbursement rates go into place.
Nature Medicine Just Published the AI Mental Health Audit Framework the FDA Hasn’t Written Yet
Nature Medicine's clinically validated AI chatbot audit framework arrives as FDA still lacks generative AI mental health approval standards—here's what trial…
Exmoor market health hub helping farmers discover hidden conditions
Exmoor Rural Health Hub runs screening clinics twice a month at Cutcombe Market in Wheddon Cross.
Bronchiectasis: How To Manage Your Mental Health and Stay Connected
If daily symptoms and flares take their toll on your mental health, you’re not alone. A pulmonologist shares how to cope and manage.
Black Book: Australia's 2027 Health IT Market Shifts From Pilots to Proof
Post-HIC 2026, provider study finds interoperability, clinical cyber continuity and statewide EHR execution will dominate the next buying cycle NORTH SYDNEY, AU / ACCESS Newswire / August 9, 2026 / Black Book Research today announced the publication ...
California Prop 44 would force health clinics to spend 90% on patient care
A measure aimed at changing how community health clinics spend taxpayer dollars is heading to the ballot box this November. Voters will decide the fate of Proposition 44. Supporters say it will increase accountability, but opponents warn it could threaten services patients rely on.
Remote Area Medical brings free health clinic to Bennington
Remote Area Medical is holding a free two-day dental and vision clinic at Mount Anthony Union Middle School in Bennington — the organization’s fourth visit to the area.
Austin Public Health offering 3 vaccine clinics during August
Austin Public Health will hold vaccine clinics in August for National Immunization Awareness Month.
David Sinclair Launches Lifespan Media Platform for Longevity Science
David Sinclair launches Lifespan media platform to improve public understanding of longevity science research and clinical trials.
Deputies shoot armed person ‘experiencing a mental health episode,’ Riverside County Sheriff’s Office says
Deputies shot an armed person “experiencing a mental health episode” in Moreno Valley Friday, according to the Riverside County Sheriff’s Office. Sheriff’s deputies and a clinical therapist from th…
St. Petersburg psychologist shares advice for long-term health improvements
Clinical psychologist Dr. Elizabeth Bendick in St. Petersburg emphasizes that improving overall health begins with establishing consistent daily habits rather than overwhelming life overhauls.
Metro Health hosts back-to-school vaccine clinic for Immunization Awareness Month
San Antonio Metro Health hosts a back-to-school immunization event Aug. 9, 9 a.m. to 1 p.m. at Wheatley Heights Sports Complex. No appointment needed. Vaccines via state programs, plus family resources. Supplies limited.
Tashiba Williams: How Mobile Wound Care Is Expanding Healthcare Access
As a family nurse practitioner and the founder of ADA Family Health Clinic, a mobile wound care and primary care practice serving patients across Texas and Louisiana, Williams represents healthcare professionals whose clinical experience may contribute to leadership and care-delivery discussions.
How Cohere Health digitizes clinical policies using Amazon Bedrock AgentCore
In this post, you learn how Cohere Health built a multi-tenant agentic architecture on AgentCore using AgentCore Runtime’s secure MicroVM isolation, unified tool access through AgentCore Gateway, AgentCore Memory, and the Agent Skills open standard to rapidly scale policy digitization capabilities, while preserving transparency, version control, and human oversight.
Essentia Health-Duluth Clinic welcomes family medicine specialist Dr. Nicholas Woessner
Dr. Nicholas Woessner, a doctor of osteopathic medicine specializing family medicine, is thrilled to join the Essentia Health-Duluth Clinic.
Seattle-area community clinics to lose family medicine residents
A Providence Swedish training program plans to cut ties with three community clinics that have historically served lower-income patients of color.
A third clinic settles with DOJ over trans care
Anthony Fauci held in contempt, crackdowns on the organ donor network, and more health news from Morning Rounds
Health clinics provided to Colorado students in Cherry Creek Schools before return to class
Health clinics provided to Cherry Creek Schools students before return to classes
A clinically validated framework for auditing AI chatbot behavior in mental health interactions
Nature Medicine - Across 810 conversations, an evaluation framework finds that AI chatbots often amplify simulated users’ psychological vulnerabilities, revealing persistent safety risks in...
New heart drug targeting inflammation falls short in clinical trial
The ZEUS trial fell short, but Novo Nordisk still has high hopes for HERMES and ARTEMIS.
Texas rural clinics turn to telehealth
Clinics with better internet connections are now offering telehealth services to patients who can’t do it from their homes.
AHF • ‘We the People’ Coalition Merges Faith & Politics to Engage Black Voters -- L.A. Gospel Concert & Panel, Sat., Aug. 8th
AIDS Healthcare Foundation (AHF), the world's largest HIV/AIDS healthcare organization, currently provides medical care and services to more than 1.75 million clients in 45 countries. With more than 7,000 employees worldwide, AHF now has treatment clinics and other operations in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region, and Europe. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth, and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare.
VA accelerates electronic health record rollout
After years of delays, the Department of Veterans Affairs says its federal electronic health record (EHR) program is now firmly back on track. VA Secretary Douglas Collins has accelerated the program with a renewed goal: full deployment across all VA medical centers by 2031. A major governance overhaul, replacing multiple competing councils with a single decision-making body, has cut through bureaucratic delays and allowed the VA to move faster and more consistently. Deputy Secretary Paul Lawrence has taken a hands-on role, including visiting deployment sites and holding daily meetings with Oracle Health to ensure front-line clinicians have what they need. Here’s how the rollout is going, according to the VA: The federal EHR has only experienced four outages since December 2025. The system has gone nearly two consecutive years without a major incident. It is currently live at six sites, supporting care for over 188,000 veterans. The system creates a lifelong medical record, integrating data across the VA, the Department of Defense and private community providers. With the first new deployments underway and four Michigan medical centers already live in 2026, the VA is entering its first true expansion phase since the program’s reset. Officials say the system’s improved stability, streamlined governance and standardized national workflows have cleared the obstacles that once stalled progress. With 13 sites scheduled for deployment in 2026 and a market‑based rollout strategy guiding future waves, the department believes it’s finally positioned to move at scale toward a modern, fully interoperable EHR, advancing steadily toward its goal of reaching every VA medical center in five years.
US Stand Up for Science movement expands to Europe
A grassroots movement by scientists in the US pushing back against threats to academic freedom is setting up a Swiss outpost to take the movement global. Stand Up for Science started in February 2025 to protest against politically-motivated grant cancellations by the Trump administration. Since then, it has organised numerous rallies by scientists and turned into a broader campaigning organisation, supporting “pro-science” political candidates and attempting to impeach Robert F. Kennedy Jr, the health and human services secretary the group accuses of advancing “quack” science. Now, Stand Up for Science is establishing a Swiss office to take some of its campaigning beyond the US, and its leader is urging European academics to organise similar pro-science groups in case they face similar threats in Europe. There will likely be “spillover” to Europe from what the Trump administration is attempting in the US, said Colette Delawalla, chief executive of Stand Up for Science, who last month returned from a tour of Europe. “Are we going to see a Trump-style scientific [. . .] take over in the same way?” she asked.Delawalla, who is doing a PhD in clinical psychology, said she was driven to help found the organisation after the Trump administration started cancelling health research grants in politically taboo topics, such as transgender people, diversity and HIV, in early 2025. Since then, the administration has introduced several other measures that infringe academic and institutional autonomy.It threatened to cut Harvard University’s federal funding unless the university accepted a “critical mass” of new faculty and students to create “viewpoint diversity.” And this year, it proposed explosive new rules that would allow political appointees at research funders to screen grants to make sure they “advance the president's policy priorities.”US scientists have been at times stunned by the volume of announcements, and the country’s researchers were relatively unprepared. “We sit in front of the fire hose every day,” said Delawalla. For this reason, European scientists need to prepare now for similar assaults. “If you've got a little bit of extra time to start thinking through, and making those preparations and building community and solidarity,” then European researchers will “start five steps ahead of where we were.” She plans to return to Paris in September to share experiences with concerned French academics. Is Le Pen the same?During her European tour, Delawalla said that French academics were beginning to worry about a National Rally (RN) victory in presidential elections next year. She said there were “chilling similarities” between Trump and Marine Le Pen, the RN’s likely candidate. However, so far, the RN hasn’t proposed anything nearly as radical as the Trump administration has carried out. Its current manifesto is all but silent on university and research policy. Le Pen’s 2022 manifesto bemoaned a lack of French R&D spending, including in fundamental research, and promised to modernise labs and strip away grant bureaucracy. The party’s 2024 European election manifesto explicitly supported the Erasmus+ student exchange programme, scientific exchange and joint European technology projects. However, a Le Pen victory next year could see France drastically cut its contribution to the EU, which would hit the budget for science and innovation. Meanwhile, more restrictive immigration policies could hit university recruitment of faculty and students. Climate science denial?As heatwaves and wildfires have ravaged France, the RN has sought to distance itself from previous comments casting doubt on climate science.In the UK, the radical-right party Reform UK, now second in the polls, denied climate research in a draft of its 2024 election manifesto, but its leader, Nigel Farage, then appeared to quietly U-turn and said he was “not arguing the science.” By contrast, Trump has repeatedly and explicitly denied climate change science, in 2025 calling it “the greatest con job.” Like the RN, Reform UK has been light on research and university policy. However, it did say in its 2024 manifesto that universities should suffer “heavy financial penalties” for allowing “political bias or cancel culture” on campus, building on laws brought in by a previous Conservative government. Ahead of September state elections in Saxony-Anhalt in Germany, the poll-leading Alternative for Germany has proposed abolishing gender studies and postcolonial studies, and promised money for “critical” climate research and studies of Islam. Starts with rhetoricEven if European radical right parties aren’t currently planning the draconian policy measures of the Trump administration, Delawalla said that academics should not be complacent, and fight even small funding restrictions or anti-science talk from the start. “It starts off with sowing distrust about institutions,” she said. “It starts off with these small things, and then all of a sudden it's there.” There are other, more established science and university advocacy groups in the US aside from Stand Up for Science. But the group stands out because of Delawalla’s refusal to attempt to appear politically bipartisan or conciliatory. “I firmly believe that the US is experiencing fascism,” she said. “We’re not trying to win over the super Maga people,” she said, “and we never have been.” The lesson of the US is that even if universities or other institutions capitulate to government demands, this doesn’t save them from cuts and restrictions. “It doesn’t matter what people do,” she said. Global “pseudoscience”Another aim of Stand Up for Science’s push into Europe is to better coordinate a campaign to protect people in poorer countries from what the group describes as “pseudoscientific exploitation,” trials outside the US used to build a case against things like vaccines. Earlier this year, the group sent an investigator to Guinea-Bissau to investigate a controversial, Danish-run Hepatitis B vaccine project funded by the US Centers for Disease Control and Prevention.The study would have withheld a proven vaccine from newborns, Stand Up for Science argued in a briefing it presented to Congress, risking their health. Significantly, the research group based in Guinea-Bissau, known as Bandim, focuses on the “non-specific effects” of vaccines: impacts on health beyond preventing the target disease. Related articlesEuropean researchers sound the alarm that Trump rule changes will hit cooperationData corner: which fields of health science is the US curbing? The US ‘golden age’ science strategy: what Europeans need to know The suspicion is that the study was funded as part of an attempt to shop around for results that could help build a case against vaccines in the US, said Delawalla. “This is just code for vaccines cause autism,” she said.Bandim has put out a rebuttal of Stand Up for Science’s criticisms, arguing its work has uncovered a number of vaccine side effects, both positive and negative, which need to be taken into account in public health. However, Congressional Democrats took up the Stand Up for Science cause, and in February, Guinea-Bissau said it had permanently halted the study. WatchdogBut for Delawalla, this is not the end of the fight. Kennedy has made a number of health claims that scientists think lack evidence, such as the idea that seed oils cause inflammation, for example. Delawalla worries that more studies could be launched in poorer countries to fish around for evidence to support this agenda. Stand Up for Science is talking to African science organisations to create a kind of “watchdog” to scrutinise any further trials. “Outsourcing the investigation to some of the most vulnerable children in the world who are desperate [. . .] is fundamentally wrong,” she said.
Experts share MRI efficiency strategies that could raise revenue by upward of 60%
Workflow redesigns have the potential to improve MRI throughput by 20%, while AI-based protocol optimization could boost efficiencies by another 35%, experts write in Clinical Imaging.
Clopidogrel monotherapy bests aspirin when patients with diabetes undergo PCI
After an initial period of DAPT, what's the best next step? A new analysis reviewed data from the SMART-CHOICE 3 clinical trial.
Federal regulators invite industry, researchers, and lobbyists to closed-door meetings on clinical AI
Federal health officials invited tech companies and lobbyists to closed-door meetings as they seek to boost adoption of clinical AI.
New Golisano Children’s Mobile Health Clinic to Serve Communities Throughout Rochester
University of Rochester Medicine Golisano Children's launched its Pediatric Mobile Clinic Initiative with a ribbon-cutting ceremony attended by community leaders, healthcare providers, donors, and Rochester leaders.
Sanofi suspends chronic lung disease phase 2 study, tied to ‘strategic business reasons’
Sanofi halted a phase 2 trial testing a monoclonal antibody, SAR445399, in non-cystic fibrosis bronchiectasis, Fierce Biotech has learned. The trial, which began only back in April, was a randomized, double-blind, placebo-controlled study to measure the reduction in mucus plug score following treatment with SAR445399 compared with placebo in adults aged 18 to 80 years with NCFB, a chronic lung disease. The trial was officially reported as halted on July 29, the day before Sanofi’s second-quarter earnings call. The decision to pause the trial was made “as part of a company-wide portfolio review for strategic business reasons,” and not due to safety concerns, a Sanofi spokesperson told Fierce. The move to pause the NCFB trial comes during a trying time for Sanofi following a year filled with a series of trial fails. In February, the French pharma ousted CEO Paul Hudson and appointed Merck KGaA leader Belén Garijo, M.D., Ph.D., to steer the ship. Since then, Garijo has been doing a deep dive on correcting the company’s strewn R&D and clinical strategies. On July 24, Sanofi scrapped amlitelimab for atopic dermatitis, despite its lore as being a potential $5 billion blockbuster. During its second-quarter report, the company abandoned two more assets, balinatunfib and itepekimab, following failed trial results in psoriasis and chronic obstructive pulmonary disease, respectively. SAR445399, only first revealed by Sanofi in 2023, is an anti-interleukin-1 receptor 3 monoclonal antibody developed to block the interleukin 1, 33, and 36 cytokine pathways. These pathways can be important in chronic immune-related dermatologic diseases, such as atopic dermatitis and hidradenitis suppurativa, as well as respiratory conditions, such as NCFB. Related Sanofi’s new CEO ‘looking deeply’ at late-stage pipeline as clinical clearout continues NCFB affects roughly half a million people in the U.S., with a global incidence of greater than one million cases. In August 2025, Insmed received FDA approval for Brinsupri, a DPP1 inhibitor targeting neutrophil activation, for treatment of NCFB in adults and kids ages 12 and older. The British biotech Infex Therapeutics showed promising NCFB phase 2a data using their monoclonal antibody, INFEX702, which acts by disabling Pseudomonas aeruginosa, a bacteria known to be a major pathogen of NCFB. Sanofi is currently running a separate phase 2 study testing SAR445399 as a potential treatment for the inflammatory skin condition hidradenitis suppurativa.
Swallowing faecal capsules reduces peanut allergy in six adults
Altering the gut microbiomes of people with peanut allergy using faeces donated from an allergy-free individual improved their peanut tolerance in a clinical trial
Silver Bay clinic closure draws concerns over rural health care access
Aspirus Lake View’s Silver Bay Clinic will close Dec. 31. The health care provider announced that future clinic visits, laboratory services and radiology will relocate to the Lake View Two Harbors Clinic. The Minnesota Department of Health held a hearing July 28 to provide a forum for community members to discuss the change in services....
Procter & Gamble acquires Thorne for $3.8bn in bet on science-backed supplement growth
The deal, expected to close in Q4 2026, brings Thorne's clinically validated, practitioner-trusted supplement portfolio into P&G's consumer health stable — signalling mainstream consumer goods giants' accelerating move into premium VMS
CVS Health enhances its direct-to-consumer weight management offerings to improve access, affordability, care and support for GLP-1 medications
CVS Health® today announced a revamp of its weight management program, making it easier for eligible adults to access clinical care, navigate medication costs and get ongoing support for GLP-1 therapy.
LLMs better than docs at providing clinical context for imaging orders
The inclusion of clinical indication is standard for imaging requisitions, but the information provided is often vague and leaves out useful context that could help radiologists.
Kansas just affirmed that abortion politics still matter - Live Updates
Voters rejected a measure that was yet another ploy to restrict the right to abortion in the state.
The Beauty Of Settled Science
Commenters convinced me I made a subtle mis-step in my framing of Psychology Research Is Mostly Fine. My framing emphasized that social priming studies had failed to replicate, but that many other subfields of psychology hadn’t. This naturally led commenters to point to failed replications in other subfields. Although none of these were as bad as social priming, few or none were entirely problem-free. Instead of emphasizing the difference between social priming and other subfields, I should have emphasized the difference between settled science and novel research. Here are some of my favorite psychology findings: The brain is sculpted by reinforcement learning, and a key driver of this learning is a prediction-error-based algorithm located in the nucleus accumbens and implemented through dopamine. Psychedelic drugs exert their effects through 5-HT2A receptors, pointing to a role for these receptors in some sort of construct like the balance between priors and new evidence. Certain cognitive functions are localized to certain brain areas (for example, impulse control to the frontal lobes; linguistic structure to Broca’s area, linguistic meaning to Wernicke’s area. But injure one of these areas, or render a certain function useless (eg a blind person having no more use for their visual cortex), and these mappings can gradually shift - suggesting that neurons are general-purpose compute whose specialization is a contingent fact about convenience and efficiency rather than a necessity. Most personality traits and general capabilities are about 50% genetic and 50% random, with little role for family environment or childhood history, with a few notable exceptions like partisan preference. Recent research complicates this story, but the further you go from this basic picture, the gnarlier the chains of indirect causation you require. Neurons fire together in “brain waves”, whose exact frequency corresponds with the character of consciousness; These divide neurons into natural subpopulations and linked graphs. The gamma rhythm corresponds surprisingly well to items in conscious awareness. GABA receptors seem to be involved in something like relaxation. By hitting different GABA receptors in different ways, you can modulate the exact type of relaxation you produce. Hitting GABA-A directly is too powerful and can cause dangerous levels of sedation, but allosteric modulation of GABA is an incredibly fruitful strategy that underlies drugs from benzos to barbituates to alcohol. If you know your GABA-A subunits, you can target specific subtypes of relaxation; for example, Ambien hits GABA-A1 and induces sleep. Memory divides somewhat fuzzily into bins of immediate-sensory, short-term, and long-term, with separate retrieval and storage functions, and separate systems for declarative vs. procedural learning. These can be harmed selectively, usually by hippocampal injury, so that some patients can remember their life stories but not form new long-term memories, or learn new skills like bike-riding but not new facts. The exact substrate of memory is unclear but seems to involve new synaptic connections between neurons in at least some way. The ability of modern psychology and psychiatry to treat mental illness is real but limited. SSRIs work for half or slightly fewer than half of patients; antipsychotics work with extreme side effects; benzodiazpines work but produce addiction and tolerance in many (not all) people. Most supplements are stuck in Poor Quality Study Replication Crisis Hell, but melatonin and l-theanine stand out as especially promising. Psychotherapy works with moderate effect size, but (with a few exceptions) seems to be more about the relationship with the provider than the details of the therapy itself. Mental hospitalization can sometimes defuse immediate crises but work less well than mental hospitals would like, with some studies showing overall negative effects. Schizophrenia is mostly genetic, but risk also increases with prenatal infection (especially rubella) and obstetric complications; there is suggestive evidence for roles of social stress and drug use (with psychedelics and marijuana making things worse, and nicotine if anything making things better). Bipolar and schizophrenia are so closely linked on a pathophysiological level that it seems like they might be the same disease; on the clinical level, they do seem to follow two separate courses/prognoses but can sometimes surprise clinicians by eg someone who seemed condemned to permanent schizophrenia unexpectedly recovering. The brain’s native reinforcement learning algorithms cash out in the phenomena of classical and operant conditioning; different reinforcement schedules reinforce at different levels, which can be exploited by bad actors to make especially compelling products (eg slot machines). None of these are immune to doubt. A few are speculative; one or two are genuinely unorthodox. But they’re all a step above one p = 0.049 paper that might not replicate. If they get overturned, they’ll be overturned by the same sort of genuine scientific shift that replaced Ptolemy with Copernicus or Lamarck with Darwin, not some sort of sordid discovery about someone entering random numbers into a spreadsheet. In 2008, Eliezer Yudkowsky wrote about The Beauty Of Settled Science: If you only care about scientific issues that are controversial, you will end up with a head stuffed full of garbage. The media thinks that only the cutting edge of science is worth reporting on. How often do you see headlines like “General Relativity still governing planetary orbits” or “Phlogiston theory remains false”? So, by the time anything is solid science, it is no longer a breaking headline. “Newsworthy” science is often based on the thinnest of evidence and wrong half the time—if it were not on the uttermost fringes of the scientific frontier, it would not be breaking news. Scientific controversies are problems so difficult that even people who’ve spent years mastering the field can still fool themselves. That’s what makes for the heated arguments that attract all the media attention. Worse, if you aren’t in the field and part of the game, controversies aren’t even fun. Don’t be embarrassed to read elementary science textbooks, either. If you want to pretend to be sophisticated, go find a play to sneer at. If you just want to have fun, remember that simplicity is at the core of scientific beauty [...] A steady diet of science news is bad for you: You are what you eat, and if you eat only science reporting on fluid situations, without a solid textbook now and then, your brain will turn to liquid. Psychology isn’t centrally the new paper in Annals Of Recently-Breaking News saying that an n=5 study showing that large portion sizes increase support for terrorism. Psychology is centrally ideas like brain waves, GABA receptors, reinforcement learning, twin studies, and connectionism. People who think differently are worrying too much about BREAKING NEWS!!!, and should stop. The key distinction isn’t “recent research in social psychology” vs. “recent research in cognitive/bio/behavioral psychology”, as my essay last week unfortunately implied. It’s recent research in general vs. the deposit of settled science, battle-tested hypotheses, and carefully-earmarked speculation. And part of the reason social priming in particular was such a disaster was that it defied that heuristic, building itself up over hundreds of studies until it approached or even entered the pantheon of settled science - before collapsing (5-HTTLPR was also sort of like this). This isn’t a claim that settled science is always right - Freud was “settled science” for a long time - just that there’s an intuitive distinction between the level of credence you should have in the existence of power posing vs. the existence of Broca’s Area. (I compounded this error by calling the last post “Psychology Research Is Mostly Fine”, which suggested I was talking about the new research rather than the settled science. I actually meant to distinguish between research-psychology-the-field vs. clinical-psychology-aka-therapy, but this framing unintentionally pushed against the point I wanted to make) Some commenters on the previous article understood this point, but challenged its weight. It’s very cool, they said, to know how many neurons are in which brain lobe, but the main way that Psychology affected their lives was through bad clickbait studies used to buttress dumb policies; some p = 0.049 study says that exposure to microaggressions makes minorities’ brains shrivel into raisins, and now their company has to implement punitive DEI or be sued for hazardous work conditions. I won’t dispute this as an accurate description of how the sausage gets made, but it’s worth examining the trains of thought that connect this observation to a campaign against psychology in general: The dumb woke psychology was wrong and bad, and I don’t have good heuristics for distinguishing dumb woke psychology from other psychology, so I’m going to assume it’s all wrong and bad. The dumb woke psychology was wrong and bad; it seems useful to punish/discredit psychology as a whole to assist my campaign against it, so for propaganda purposes I will try to discredit psychology as a whole. To people in the first camp, my response is: come on, your heuristics aren’t that bad. “Microaggressions makes minorities’ brains shrivel up like raisins” is in the woke category; “the hippocampal theta rhythm seems to be associated with both memory and pathfinding, suggesting an unexpected yet surprisingly compelling relationship between the two” is in the not-woke category, don’t play dumb here. To people in the second camp, my response is: deliberately exaggerated propaganda campaigns are bad and this is a confession, not an excuse. Inability to view science through anything but a political lens was what got us into this problem; doubling down on it is a temporary solution but a recipe for permanent disaster. If you pronounce entire fields of science to be acceptable collateral damage in your campaign against bad political actors, you will alienate not just scientists but patients, clinicians, and general lovers of truth. Instead, you can say the thing you mean - that woke partisans shouldn’t try to occupy and exploit the otherwise-noble science of psychology for their own political gain - and wage the same campaign with a halo rather than a comic-book-villain goatee. From the font of oracular wisdom that is Weird Sun Twitter: [ Vessel Of Spirit@VesselOfSpirit i love you all conditionally but i love the good part of you unconditionally. even if it becomes a very small part 2:11 AM · Jan 22, 2015 1 Reply · 5 Reposts · 29 Likes ](https://x.com/VesselOfSpirit/status/558084551772471298) This is how I feel about psychology1, too, but with a touch more optimism. The good part of psychology is enormous, a hoard of endless treasures. You just have to look past the headlines! 1 To play devil’s advocate - should one always be so magnamious? Astrology? Phrenology? These seem different in that their entire orientation was flawed from the start; they didn’t simply fail to find the correct constellation-personality connections, the whole project of searching for connections between constellations and personality was doomed from the start. More difficult might be asking the same question about education research, which is notoriously bad. I don’t know enough about education research to know if there’s some settled science of correct and enlightening results lurking in the background beyond the day-to-day froth of poorly-conducted and politically-motivated studies. I think if it’s 90% bad, 10% good, it’s correct to call it bad as a compact way of communicating a useful truth; I think psychology is better than that, but admit it’s a tough judgment call.
Fidji Simo had to leave OpenAI. But she’s still building a business that could find cures to chronic diseases that affect women like her
ChronicleBio is using AI to improve clinical trials and find cures for diseases like POTS.
'We are not Superman': How Boston is pushing to improve men's health
To reach more male patients, the Whittier Street Health Center in Boston runs a men’s health clinic and hosts an annual summit to focus attention on men’s health issues. In June, Boston health leaders announced plans to invest $1 million a year to help close the gap in Black men’s life expectancy.
CA is dismantling its healthcare system
In a new documentary, CalMatters goes inside a Los Angeles clinic to examine how Californians are being forced to choose between medicine and food.
Robert Wood Johnson University Hospital, Cooperman Barnabas Medical Center Named Best Hospitals by U.S. News & World Report
RWJBarnabas Health hospitals are once again recognized for delivering exceptional patient care and outstanding clinical outcomes in the 2026-2027 U.S. News & World Report Best Hospitals edition for adult healthcare services.
Capricor’s Duchenne AdCom Didn’t Fail on Science. It Failed on Statistics.
FDA's CTGTAC voted 9-3 against Capricor's deramiocel on July 30, 2026. The science wasn't the problem. The statistical methodology was — and the FDA let it get…
AI use surging for mental health help among young people
Survey researcher says popularity may help fill gap between rising national problem, shortage of clinicians — provided counsel is sound.
Methodist Healthcare acquires 18 Texas MedClinic locations in San Antonio
Methodist Healthcare announced the acquisition of 18 Texas MedClinic urgent care facilities in San Antonio on Monday.
Future Warriors clinics connect Wilton youth to sports - Monadnock Ledger-Transcript
Wilton Junior Athletic Association hosted Future Warriors Summer Clinics for 3rd to 6th graders to build skills and teamwork.